Treatment of co-infection with bancroftian filariasis and onchocerciasis: A safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis

Filaria Journal

Volumn 2, Issue , 2003, Pages

  Makunde, William H ^a   Kamugisha, Leo M ^b   Massaga, Julius J ^b   Makunde, Rachel W ^c   Savael, Zakana X ^b   Akida, Juma ^b   Salum, Fred M ^b   Taylor, Mark J ^d  

^a Bombo Research Station   (Tanzania)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c Bombo Regional Hospital   (Tanzania)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIFILARIAL AGENT; HERBACEOUS AGENT; IVERMECTIN; PLACEBO; SACCHARIN;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BLOOD ANALYSIS; CHILL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; FEVER; FILARIASIS; FOLLOW UP; FREQUENCY ANALYSIS; HEADACHE; HEART PALPITATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LETHARGY; LYMPHADENITIS; LYMPHATIC SYSTEM DISEASE; MALE; MICROFILARIASIS; MYALGIA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OPEN STUDY; PATIENT MONITORING; PRURITUS; SINGLE DRUG DOSE; SKIN EXAMINATION; SUPERINFECTION; WUCHERERIA BANCROFTI;

EID: 2942609088     PISSN: 14752883     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2883-2-15     Document Type: Article

References (16)

1. Kale OO: Onchocerciasis: the burden of disease. Ann Trop Med Parasitol 92:S101-S115.
2. WHO: Global programme to eliminate lymphatic filariasis. WHO/CDS/CPE/CEE/2002.28 2002 [http://www.filariasis.org].
3. Michael E, Bundy DAP, Grenfell BT: Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996, 112:409-428.
4. Maegga BTA: Onchocerciasis. In: Health and Disease in Tanzania Edited by: Mwaluko GMR, Kilama WL, Mandara MP, Murru M and Macpherson CNL. London, Harper Collins Academic Press; 1991:159-176.
5. McMahon JE, Magayuka SA, Kolstrup N, Mosha FW, Bushrod FM, Abaru DE, Bryan JH: Studies on the transmission and prevalence of Bancroftian filariasis in four coastal villages of Tanzania. Ann Trop Med Parasitol 1981, 75:415-431.
6. Evans BD, Gelband H, Vlassoff C: Social and economical factors and the control of lymphatic filariasis a review. Acta Trop 1993, 53:1-26.
7. Workneh W, Fletcher M, Olwit G: Onchocerciasis in field workers at Bay farm, Teppi coffee plantation project, south-western Ethiopia: prevalence and impact on productivity. Acta Trop 1993, 54:89-97.
8. Ottesen EA, Duke BOL, Karam M, Behbehani K: Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503.
9. Ottesen EA, Ismail MM, Horton J: The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999, 15:382-386.
10. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KSA, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekara N, DeSilva DCL, Michalski ML, Dissanaike AL: Efficacy of single dose combination of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 1998, 92:94-97.
11. Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Taylor MJ, Nutman TB: Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis 2002, 185:805-811.
12. Cross HF, Haarbrink M, Egerton G, Yazdanbakhsh M, Taylor MJ: Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet 2001, 358:1873-1875.
13. Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Lenoble-Richard D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV: An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000, 121:S147-S160.
14. Awadzi K, Edwards G, Duke BO, Opoku NO, Attah SK, Addy ET, Ardrey AE, Quartey BT: The co-administration of ivermectin and albendazole - safety, pharmacokinetics and efficacy against Onchocerca volvulus. Ann Trop Med Parasitol 2003, 97:165-78.
15. Dunyo SK, Nkrumah FK, Simonsen PE: Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg 2000, 94:437-443.
16. Addiss DG, Beach MJ, Streit TG, Lutwick S, LeConte FH, Lafontant JG, Hightower AW, Lammie PJ: Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 1997, 16:480-484.